FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: For example, PTPN11, the SHP-2 phosphatase is a regulator downstream of many TKs that could be an additional target, like the similar SHP-1 (PTPN6), which is downregulated in CML and FLT3-ITD AML.